1. Home
  2. CYTK vs LAD Comparison

CYTK vs LAD Comparison

Compare CYTK & LAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$61.96

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Logo Lithia Motors Inc.

LAD

Lithia Motors Inc.

N/A

Current Price

$258.71

Market Cap

8.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
LAD
Founded
1997
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.2B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
CYTK
LAD
Price
$61.96
$258.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
18
11
Target Price
$87.56
$380.27
AVG Volume (30 Days)
1.7M
356.3K
Earning Date
05-25-2026
05-13-2026
Dividend Yield
N/A
0.84%
EPS Growth
N/A
9.01
EPS
N/A
32.32
Revenue
$13,368,000.00
$11,821,400,000.00
Revenue This Year
$9.79
$5.09
Revenue Next Year
$302.66
$4.51
P/E Ratio
N/A
$8.12
Revenue Growth
N/A
17.20
52 Week Low
$29.31
$252.21
52 Week High
$70.98
$360.56

Technical Indicators

Market Signals
Indicator
CYTK
LAD
Relative Strength Index (RSI) 45.95 26.06
Support Level $59.25 N/A
Resistance Level $65.93 $344.10
Average True Range (ATR) 2.41 8.85
MACD -0.28 -1.36
Stochastic Oscillator 25.44 13.46

Price Performance

Historical Comparison
CYTK
LAD

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About LAD Lithia Motors Inc.

Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.

Share on Social Networks: